Oric Pharmaceuticals

ORIC

Börsenwert 1,37 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Nextech Invest Zurich, Switzerland	54,2 Mio. $	–	–	–
2	2 BlackRock New York	52,3 Mio. $	+2,68 Mio. $	+270.937	+6 %
3	3 VR Adviser New York	45 Mio. $	–	–	–
4	4 Fidelity Investments Boston, Massachusetts	44,9 Mio. $	-5,35 Mio. $	-541.541	-11 %
5	5 Frazier Life Sciences Management Palo Alto, California	42,5 Mio. $	–	–	–
6	6 Viking Global Investors Stamford, Connecticut	41 Mio. $	–	–	–
7	7 Alkeon Capital Management New York	40 Mio. $	+988.730 $	+100.000	+3 %
8	8 Column Group San Francisco, California	36,3 Mio. $	–	–	–
9	9 EcoR1 Capital San Francisco, California	35 Mio. $	–	–	–
10	10 Vanguard Group Malvern, Pennsylvania	32,5 Mio. $	-320.497 $	-32.415	-1 %
11	11 Commodore Capital New York	20,5 Mio. $	–	–	–
12	12 State Street Boston, Massachusetts	19,9 Mio. $	-3,14 Mio. $	-318.059	-14 %
13	13 Boxer Capital San Diego, California	17,8 Mio. $	–	–	–
14	14 NEA Management Company Timonium, Maryland	15,4 Mio. $	–	–	–
15	15 First Turn Management Del Mar, California	14,9 Mio. $	-641.913 $	-64.923	-4 %
16	16 Avidity Partners Management Dallas, Texas	14,8 Mio. $	+14,3 Mio. $	+1.447.119	Neu
17	17 ArrowMark Colorado Holdings Denver, Colorado	13,9 Mio. $	+800.733 $	+80.986	+6 %
18	18 Vivo Capital Palo Alto, California	13,1 Mio. $	+80.502 $	+8.142	+0,6 %
19	19 Geode Capital Management Boston, Massachusetts	13,1 Mio. $	+502.482 $	+50.821	+4 %
20	20 Balyasny Asset Management Chicago, Illinois	11,6 Mio. $	+11,2 Mio. $	+1.131.066	Neu
21	21 T. Rowe Price Associates Baltimore, Maryland	11,4 Mio. $	-735.042 $	-74.342	-6 %
22	22 Silverarc Capital Management Boston, Massachusetts	11,3 Mio. $	+234.111 $	+23.678	+2 %
23	SL 23 Siren LLC Greenwich, Connecticut	10,3 Mio. $	+10 Mio. $	+1.007.575	Neu
24	EC 24 Euclidean Capital New York	10,1 Mio. $	–	–	–
25	25 Superstring Capital Management New York	9,7 Mio. $	+9,39 Mio. $	+949.522	Neu

Oric Pharmaceuticals ORIC Börsenwert 1,37 Mrd. $

Oric Pharmaceuticals

ORIC

Börsenwert 1,37 Mrd. $